November 2024
168 articles-

Nov 25 · 22:47Biotechnology Daily
Pain medicine biotech Latigo taps CRO founder for CMO role
-

Nov 25 · 22:46Biotechnology Daily
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
-

Nov 25 · 22:44Bio Business News
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
-

Nov 25 · 22:42Bio Business News
Denmark's Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
-

Nov 25 · 22:41Bio Business News
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
-

Nov 25 · 22:40Bio Business News
Avantor sells clinical services unit to private equity firm for $650M
-

Nov 25 · 20:56Market Watch
Charlotte Airport Workers Voting on Whether to Strike During Busy Thanksgiving Travel Week
-

Nov 24 · 22:35Biotechnology Daily
Pfizer, BioNTech's combo mRNA shot is latest to be defeated by influenza strain B
-

Nov 24 · 22:33Biotechnology Daily
'We're pretty prolific': Lilly Catalyze360 looks to connect with emerging biotechs across 'all areas'
-

Nov 24 · 22:31Biotechnology Daily
FDA clears its first at-home blood test for syphilis
-

Nov 24 · 22:30Biotechnology Daily
FDA clears Cresilon’s bloodstopping gel for severe wounds
-

Nov 24 · 22:27Bio Business News
FDA allows BioNTech-MediLink ADC trial to resume with lower, safer doses
-

Nov 24 · 22:26Bio Business News
Polyrizon pays $3M for license to SciSparc's preclinical cannabinoid pain therapy
-

Nov 24 · 22:25Bio Business News
GI robotics developer Neptune Medical raises $97M, launches Jupiter Endovascular
-

Nov 24 · 22:24Bio Business News
Genentech to shut down cancer immunology research department amid broader R&D rethink
-

Nov 24 · 21:50Market Watch
Bitcoin Ticks Closer to $100,000 in Extended Surge Following US Elections
-

Nov 21 · 20:48Biotechnology Daily
'We are firing on all cylinders': Bayer pharma BD chief says group overhaul not slowing dealmaking
-

Nov 21 · 20:45Biotechnology Daily
HistoSonics nets $102M to boost its sound beam-powered liver cancer therapy
-

Nov 21 · 20:43Biotechnology Daily
In the wake of Céline Dion's diagnosis and comeback, stiff-person syndrome researchers and advocates march toward a cure
-

Nov 21 · 20:41Biotechnology Daily
Using AI and brain implants, researchers reconnect ALS patient with their lost voice
-

Nov 21 · 20:36Bio Business News
Turnstone narrows cell therapy focus to 'high unmet need' tumor indications
-

Nov 21 · 20:34Bio Business News
Following rejection and retractions, Lykos caps off chaotic week by cutting 75% of staff
-

Nov 21 · 20:05Bio Business News
ArriVent licenses ADC from $100M biobuck deal with Aarvik
-

Nov 21 · 20:03Bio Business News
Cancer-focused Actuate is latest biotech on Nasdaq after $22.4M IPO